PrimeraDx is dedicated to the emerging field of molecular diagnostics. The company is developing multiplexed, quantitative and cost effective assays using its proprietary STAR technology implemented on the ICEPlex instrument platform. STAR combines quantitative PCR with the ability to multiplex up to 60 targets in a single sample. The Company’s initial products are for infectious disease management. PrimeraDx plans to extend its focus into oncology to support cancer therapy management through diagnostic, prognostic, staging and therapeutic monitoring.
PrimeraDx is a privately held company located in Mansfield, Massachusetts.
Be the recognized world leader in medical technology, by transforming collaborative innovation into reliable and versatile products for the advancement of patient care.
Dedicated to Quality
PrimeraDx is ISO 13485: 2003 certified.